Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has signed an exclusive distribution agreement with MineBio, a leading Chinese supply chain and logistics organization

CARBOGEN AMCIS manufacturing license advances services in China - Pharmafile

Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has been successfully granted Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA). This marks a significant step in the company’s expansion into the Chinese pharma market. The Shanghai site excelled in all regulatory expectations when good manufacturing practices (GMP) […] The post CARBOGEN AMCIS manuf…

Atelerix signs exclusive agreement with MineBio

Atelerix, a biotech company, has announced it has signed an exclusive distribution agreement with MineBio, a Chinese supply chain and logistics organisation.

Biotech business Atelerix signs distribution deal to expand into China

The firm has signed an exclusive distribution agreement with MineBio, a leading Chinese supply chain and logistics organisation